Chrome Extension
WeChat Mini Program
Use on ChatGLM
VIPCreated with Sketch.

Multicenter Open Label Phase 3 Benefit Study of Isatuximab Plus Lenalidomide and Dexamethasone With/without Bortezomib in the Treatment of Newly Diagnosed Non-Frail Transplant Ineligible Multiple Myeloma Elderly Patients. IFM2020-05

Arthur Bobin,Cyrille Hulin,Jerome Lambert,Aurore Perrot,Salomon Manier,Lydia Montes,Arnaud Jaccard,Lionel Karlin,Pascal Godmer,Denis Caillot,Thomas Chalopin,Christophe Roul,Clara Mariette,Sophie Rigaudeau,Jacques Delaunay,Claire Dingremont,Alberto Santagostino,Mamoun Dib,Margaret Macro,Mourad Tiab,Kamel Laribi,Emmanuelle Bourgeois Petit,Claire Calmettes,Frederique Orsini Piocelle,Benoit Bareau,Reza Tabrizi,Laure Vincent,Mohamad Mohty,Cyrille Touzeau,Jill Corre,Philippe Moreau,Thierry Facon,Herve Avet Loiseau,Xavier Leleu

BLOOD（2023）

Cited 0|Views9
Key words
International Myeloma Working Group
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined